Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi. - Wikidata - wikimedia - TriplyDB

Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi.

Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi.

http://www.wikidata.org/entity/Q36422127

about

Enhancing oral vaccine potency by targeting intestinal M cells Modulation of immune response in experimental Chagas disease Differential regional immune response in Chagas disease Inhibition of HIV-1 replication in human monocyte-derived macrophages by parasite Trypanosoma cruzi.Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.CD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development?Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.3-Hydroxy kynurenine treatment controls T. cruzi replication and the inflammatory pathology preventing the clinical symptoms of chronic Chagas disease.Tc52 amino-terminal-domain DNA carried by attenuated Salmonella enterica serovar Typhimurium induces protection against a Trypanosoma cruzi lethal challenge.Mucosal immunization with live attenuated Francisella novicida U112ΔiglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat model TcVac3 induced control of Trypanosoma cruzi infection and chronic myocarditis in mice.Biological and immunological characterization of recombinant Yellow Fever 17D viruses expressing a Trypanosoma cruzi Amastigote Surface Protein-2 CD8+ T cell epitope at two distinct regions of the genome Oral exposure to Trypanosoma cruzi elicits a systemic CD8⁺ T cell response and protection against heterotopic challenge A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8(+)T cell mediated immunity against Trypanosoma cruzi.Developments in the management of Chagas cardiomyopathy.Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease.Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme disease Active and passive immunizations with Bordetella colonization factor A protect mice against respiratory challenge with Bordetella bronchiseptica Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy.Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.Vaccination approaches against Trypanosoma cruzi infection.DNA vaccines: a rational design against parasitic diseases.The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan.Salmonella enterica as a vaccine carrier.Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.Prophylactic and therapeutic DNA vaccines against Chagas disease.Attenuated Salmonella sp. as a DNA Delivery System for Trypanosoma cruzi Antigens.Attenuated Salmonella enteritidis E23 as a vehicle for the rectal delivery of DNA vaccine coding for HIV-1 polyepitope CTL immunogen.Oral vaccination with inhibin DNA delivered using attenuated Salmonella choleraesuis for improving reproductive traits in mice.Differential immune response in mice immunized with the A, R or C domain from TcSP protein of Trypanosoma cruzi or with the coding DNAs.The efficacy, biodistribution and safety of an inhibin DNA vaccine delivered by attenuated Salmonella choleraesuis.Prizes and parasites: incentive models for addressing Chagas disease.Nasal immunization with inhibin DNA vaccine delivered by attenuated Salmonella choleraesuis for improving ovarian responses and fertility in cross-bred buffaloes.Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection.

P2860

Q21089613-380773D1-9D41-490E-9B19-41CB21AB09FF Q27022885-77F7F35C-5842-4732-9CBA-000933DA7366 Q33479115-A63DC65A-7972-4B9E-8485-0CD3BF8336E4 Q33518515-650EC094-D1FE-48C5-B28C-9BDA00952DC4 Q33656471-8FD83ACA-DAB2-40E0-AFC1-9A49B999AAD6 Q33914939-612A1033-211B-4620-830D-685F3C94243C Q33916310-549C75E4-D23E-44E2-BFCB-53B3BCDCCCF0 Q34058668-5C0983B0-D735-496C-BDE6-477F6EBC0BA2 Q34298752-278FB6B4-8AEF-4CE4-9AEB-C2118E387097 Q34464553-34B9D24D-4CF3-43E3-94C8-97632A14F9C9 Q34651261-BAF70578-B653-4C3C-8E4E-BD9956843A25 Q34732681-9C0D90E6-DBFF-42E0-A009-828A186F20D4 Q35139381-874987AE-68D0-45B6-8F71-4E893B420CCE Q35166960-DB574291-9F90-4750-A7CD-D1A879486C70 Q35581314-E6436D4D-0975-44C4-A4F3-8A2218EB493E Q36429150-FA4F5161-010B-4D08-BBD9-E10BC868C625 Q36737035-3E402CDB-3AF6-4C4C-AC6E-63FA95689A33 Q36844914-077266F9-8B33-4D89-A6E9-669465F272FD Q36898061-EA5AB687-0181-45C8-8C74-104AB2162CD7 Q37075478-72B9C183-BE22-4052-A997-4DED53F44D18 Q37145013-833A7F98-691E-4CD5-A416-D29952D09C23 Q37309281-5CDEE3A6-D334-4CE3-AD53-487E029F1A8F Q37524046-B72DB844-8F9C-40CC-AB49-E3C3004ECB99 Q37682900-DEB6A83B-BD61-4A77-9CA4-577409F8494D Q37961913-DBA576CC-CF2A-4DB1-B8AB-0925CF885998 Q37970705-08F68048-4287-45AB-89DE-F3BB2817B334 Q38286350-CD1EEA3E-90C0-4FC0-A4EF-A39E5C081395 Q38426148-394CB16A-558D-4F44-9A81-BC964BA02C66 Q38778385-BC725E21-84D3-487A-A8A4-FD9F995DAF2B Q41834074-18FA3AD5-E020-455B-B66C-7D9752F3E053 Q42244329-2DA6EB00-6585-4CB0-8ACC-EAB48B0C3FFA Q44270532-75731B78-E441-4039-8E79-12CB1E8249E3 Q47111326-3660625A-3535-478F-9AC9-94D01B90399B Q47905175-5330AE60-C586-4D2C-84BA-95E8B76F89E9 Q49959375-0AF0FDF7-93EA-46D4-9F6A-4773C2447EC1 Q52619024-CAAEF270-BFF0-43CA-815B-51141BE696B7 Q55226818-EF89A0AA-E47A-434B-8450-FBB3A65E8F56

P2860

Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi.

http://www.wikidata.org/entity/Q36422127

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Oral vaccination with Salmonel ...... ity against Trypanosoma cruzi.

@ast

Oral vaccination with Salmonel ...... ity against Trypanosoma cruzi.

@en

type

label

Oral vaccination with Salmonel ...... ity against Trypanosoma cruzi.

@ast

Oral vaccination with Salmonel ...... ity against Trypanosoma cruzi.

@en

prefLabel

Oral vaccination with Salmonel ...... ity against Trypanosoma cruzi.

@ast

Oral vaccination with Salmonel ...... ity against Trypanosoma cruzi.

@en

P1433

Q36422127-DA6D4B49-57DA-427D-8730-0AB2FB5F7AA4

P1476

Q36422127-F41D8C2E-EDC4-4517-B776-84976868BF98

P2093

Q36422127-392765BD-09C3-48B6-B0AE-A07FE89549A9

Q36422127-4DC70D03-3FB7-4839-89D7-8566FE662C9F

Q36422127-60723463-EF9C-4C72-BD67-78AEFC9D2148

Q36422127-983C9F21-0504-4F91-9D4E-01DC85E97C32

Q36422127-C0C64AB0-2446-415D-9A76-E120BA898B01

Q36422127-DA689C0A-0BB5-4B9B-92FB-B45154902426

Q36422127-E15599D5-7850-4725-9A32-FFB9CD006FC8

P2860

Q36422127-07CDC743-DDE3-4794-B2B8-55B41723CF2F

Q36422127-13FC73E0-7417-493D-B425-4A291F3CBCB4

Q36422127-17667595-C8B5-4DC4-BD5F-C456A357389A

Q36422127-183C8E03-4C01-4DA3-A27A-F94968A16157

Q36422127-1C43D5B9-19D7-44A2-A108-AADE7BA636B8

Q36422127-1F5C4D8E-2C86-416F-889F-6A79081CDA3B

Q36422127-20181D3B-B514-4CD0-91DF-B2D85161BC9E

Q36422127-21554AE7-6B76-41CA-8CC2-2280643A348F

Q36422127-22A5D633-D1E4-4BBF-97DA-C1A569D020EA

Q36422127-2BB77938-DCC1-411C-8380-65E301364D47

P304

Q36422127-3161010C-938D-437D-ADD1-C09083291A62

P31

Q36422127-5897DF2F-284E-4C60-8445-2FD94C072611

P356

Q36422127-6EE7952E-1D0D-4E98-8580-115EC72E5640

P407

Q36422127-A21F5993-2958-4B27-AB75-EB24B1527511

P433

Q36422127-02F6C28D-4B31-4F40-BA5E-3E494A692C55

P478

Q36422127-33D1FD79-AD3B-4464-AEB0-476A51BE2055

P50

Q36422127-A07081A9-36B6-4EC1-83C8-7E754EAA3E9E

P5008

Q36422127-EA08F524-FF17-4E24-8BCD-0F58E1E39C03

P577

Q36422127-46E7494F-7F36-4D05-A297-6E69ACE46F55

P698

Q36422127-C0A5CFDB-B22C-4AA6-A4D5-F5EE0D53697B

P921

Q36422127-412FD5DA-DD26-4D6C-A085-6322EFADA2F7

Q36422127-491FCD4A-BB7D-4081-8F52-0DBEE32A2A63

P932

Q36422127-BF3B8303-7A24-440E-8F7B-49267D005725

P356

P1433

Infection and Immunity

P1476

Oral vaccination with Salmonel ...... ity against Trypanosoma cruzi.

@en

P2093

Carlos A Guzmán

http://www.w3.org/2001/XMLSchema#string

Fernanda M Frank

http://www.w3.org/2001/XMLSchema#string

María J Sartori

http://www.w3.org/2001/XMLSchema#string

Pablo D Becker

http://www.w3.org/2001/XMLSchema#string

Ricardo S Corral

http://www.w3.org/2001/XMLSchema#string

Silvia I Cazorla

http://www.w3.org/2001/XMLSchema#string

Thomas Ebensen

http://www.w3.org/2001/XMLSchema#string

P2860

A Toll-like receptor recognizes bacterial DNA

Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice

Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection.

Chagas disease etiology: autoimmunity or parasite persistence?

Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection.

The targets of the lytic antibody response against Trypanosoma cruzi.

CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.

Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.

Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection

CpG motifs in bacterial DNA trigger direct B-cell activation.

P304

324-333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.01163-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Emilio Malchiodi

P5008

P577

2007-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17967857

http://www.w3.org/2001/XMLSchema#string

P921

Trypanosoma cruzi

Salmonella enterica

P932

2223668

http://www.w3.org/2001/XMLSchema#string